Join the Alzheimer's Disease group to help and get support from people like you.
Alzheimer's Disease News (Page 17)
Related terms: Presenile Dementia, SDAT, Senile dementia Alzheimer's Type, Alzheimers
Benzodiazepines Not Tied to Higher Dementia Risk in Older Adults
TUESDAY, July 16, 2024 – Use of benzodiazepines is not associated with increased dementia risk in older adults, according to a study published online July 2 in BMC Medicine. Ilse vom Hofe, from ...
Hormone Therapy for Breast Cancer May Lower Dementia Risk
TUESDAY, July 16, 2024 – Hormone therapy for breast cancer might reduce a woman’s later risk of dementia and Alzheimer’s disease, a new study finds. Overall, hormone therapy is associated with a 7% l...
Some Diabetes Drugs May Lower Dementia Risk
MONDAY, July 15, 2024 – Some diabetes drugs appear to lower the risk that people with type 2 diabetes will develop dementia or Alzheimer’s disease, a new evidence review says. The risk of dementia a...
AI Better at Predicting Progression to Alzheimer's Than Standard Care
MONDAY, July 15, 2024 – An AI program has proven better than doctors at sifting through the telltale signs that indicate who with early dementia will progress to Alzheimer’s disease, a new study s...
Nightmares in Midlife May Point to Future Cognitive Decline, Dementia
FRIDAY, July 12, 2024 – Distressing dreams in middle-aged and older adults may indicate a higher risk for future cognitive decline and all-cause dementia, according to a study presented at EAN 2024,...
New Report Calls for More Research on Women's Health Issues
FRIDAY, July 12, 2024 – A new report finds research is sorely lacking on how chronic illnesses affect women, and it urged government agencies to do more to investigate how these diseases strike...
Could an App Help Predict Thinking Declines for Those With Alzheimer's?
THURSDAY, July 11, 2024 – Dutch researchers are developing an app to predict how individual cases of Alzheimer's disease will progress. Based on data from nearly 1,000 Alzheimer's patients, they...
New Research Points Towards Potential Treatment for Anorexia
THURSDAY, July 11, 2024 – Anorexia nervosa could be caused by lack of a specific brain chemical, reports a research team that has developed a possible cure for the eating disorder. Mouse studies...
FDA Approves Kisunla (donanemab-azbt) for the Treatment of Early Symptomatic Alzheimer's Disease
INDIANAPOLIS, July 2, 2024 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) approved Kisunla™ (donanemab-azbt, 350 mg/20 mL once-monthly injection for IV infusion), Eli Lilly and Company's ...
FDA Grants Traditional Approval for Leqembi (lecanemab-irmb) for the Treatment of Alzheimer’s Disease
TOKYO and CAMBRIDGE, Mass., July 06, 2023 (GLOBE NEWSWIRE) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Mas...
FDA Approves Leqembi (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's Disease
Accelerated Approval is based on Phase 2 data showing a reduction in amyloid-beta plaques in early AD patients treated with Leqembi™ Treatment with Leqembi should be initiated in patients with mild c...
FDA Approves Adlarity (donepezil transdermal system) for Treatment of Patients with Alzheimer’s Disease
BOSTON, March 14, 2022 /PRNewswire/ – Corium, Inc., a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies,...
FDA Grants Accelerated Approval for Aduhelm (aducanumab-avwa) for the Treatment of Alzheimer’s Disease
CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) – Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted...
FDA Approves Tauvid (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer's Disease
INDIANAPOLIS, May 28, 2020 /PRNewswire/ – Tauvid, a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography (PET) imaging of the brain to estimate the density and...
Actavis and Adamas Announce FDA Approval of Namzaric (memantine/donepezil) for Alzheimer's Disease
DUBLIN and EMERYVILLE, Calif., Dec. 24, 2014 /PRNewswire/ – Actavis plc (NYSE: ACT) and Adamas Pharmaceuticals Inc. (NASDAQ: ADMS) today announced that the U.S. Food and Drug Administration (FDA)...